B. Aupetit-Faisant

1.2k total citations
14 papers, 919 citations indexed

About

B. Aupetit-Faisant is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, B. Aupetit-Faisant has authored 14 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in B. Aupetit-Faisant's work include Hormonal Regulation and Hypertension (13 papers), Adrenal and Paraganglionic Tumors (4 papers) and Adrenal Hormones and Disorders (3 papers). B. Aupetit-Faisant is often cited by papers focused on Hormonal Regulation and Hypertension (13 papers), Adrenal and Paraganglionic Tumors (4 papers) and Adrenal Hormones and Disorders (3 papers). B. Aupetit-Faisant collaborates with scholars based in France, Australia and Italy. B. Aupetit-Faisant's co-authors include Bernard Swynghedauw, Jean‐Sébastien Silvestre, Claude Delcayre, Christophe Heymes, Valérie Robert, Christian Mouas, Jean‐Marie Moalic, Abdeslam Oubénaı̈ssa, A. Carayon and Leigh Pascoe and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

B. Aupetit-Faisant

14 papers receiving 886 citations

Peers

Countries citing papers authored by B. Aupetit-Faisant

Since Specialization

Citations

This map shows the geographic impact of B. Aupetit-Faisant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Aupetit-Faisant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Aupetit-Faisant more than expected).

Fields of papers citing papers by B. Aupetit-Faisant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Aupetit-Faisant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Aupetit-Faisant. The network helps show where B. Aupetit-Faisant may publish in the future.

Co-authorship network of co-authors of B. Aupetit-Faisant

This figure shows the co-authorship network connecting the top 25 collaborators of B. Aupetit-Faisant. A scholar is included among the top collaborators of B. Aupetit-Faisant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Aupetit-Faisant. B. Aupetit-Faisant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	[Role of cardiac aldosterone in post-infarction ventricular remodeling in rats]. 1999 ·PubMed ·Jean‐Sébastien Silvestre, Christophe Heymes, Abdeslam Oubénaı̈ssa, V. Robert, B. Aupetit-Faisant, A. Carayon, Bernard Swynghedauw, Claude Delcayre	3
2	Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction 1999 ·Circulation ·Jean‐Sébastien Silvestre, Christophe Heymes, Abdeslam Oubénaı̈ssa, Valérie Robert, B. Aupetit-Faisant, A. Carayon, Bernard Swynghedauw, Claude Delcayre	304
3	Myocardial Production of Aldosterone and Corticosterone in the Rat 1998 ·Journal of Biological Chemistry ·Jean‐Sébastien Silvestre, Valérie Robert, Christophe Heymes, B. Aupetit-Faisant, Christian Mouas, Jean‐Marie Moalic, Bernard Swynghedauw, Claude Delcayre	377
4	RecombinantCYP11BGenes Encode Enzymes that Can Catalyze Conversion of 11-Deoxycortisol to Cortisol, 18-Hydroxycortisol, and 18-Oxocortisol¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Paolo Mulatero, Kathleen M. Curnow, B. Aupetit-Faisant, (unknown), Celso E. Gómez-Sánchez, Franco Veglio, Xavier Jeunemaı̂tre, Pierre Corvol, Leigh Pascoe	75
5	Isolated Aldosterone Synthase Deficiency Caused by Simultaneous E198D and V386A Mutations in the CYP11B2 Gene¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), J Tourniaire, O. Richard, Paolo Mulatero, B. Aupetit-Faisant, Kathleen M. Curnow, Leigh Pascoe, Yves Morel	68
6	[Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. 1995 ·PubMed ·Xavier Jeunemaı̂tre, (unknown), Leigh Pascoe, (unknown), B. Aupetit-Faisant, C. H. L. Shackleton, Morris Schambelan, (unknown), Pierre Corvol	6
7	Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French Retrospective Multicentric Study. 1995 ·The Journal of Clinical Endocrinology & Metabolism ·B. Aupetit-Faisant, (unknown), Florence Tenenbaum, C Battaglia, Antoine Tabarin, Jacques Amar, F Kuttenn, A Warnet, M Assayag, B Chamontin	7
8	Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats 1994 ·British Journal of Pharmacology ·Richard Moreau, Hirokazu Komeichi, P Kirstetter, Yang Song, B. Aupetit-Faisant, Stéphane Cailmail, Didier Lebrec	27
9	Suramin: An inhibitor of the final steps of the mineralocorticoid pathway? 1994 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), (unknown), (unknown), G. Defaye, B. Aupetit-Faisant	3
10	A polymorphic poly-A sequence in the 5? region of the aldosynthase (CYP11B2) gene may be useful in genetic diagnosis of 11?-hydroxylase genes defects 1994 ·Human Genetics ·F. Clot, Marten Jäger, Brigitte Simon‐Bouy, J.L. Serre, B. Aupetit-Faisant, Étienne Mornet	5
11	Hypoaldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma. 1993 ·The Journal of Clinical Endocrinology & Metabolism ·B. Aupetit-Faisant, C Battaglia, (unknown), (unknown), J.C. Legrand	25
12	Hypoaldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma 1993 ·The Journal of Clinical Endocrinology & Metabolism ·B. Aupetit-Faisant	13
13	Cortisol and testosterone: Inhibitory agents of the mineralocorticoid pathway. Is there a physiopathological meaning in adrenal tumors? 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), (unknown), (unknown), G Schaison, B. Aupetit-Faisant	4
14	Plasma Levels of Aldosterone Precursors (Including the 18-Hydroxylated Compounds in this Synthesis Pathway) – A Tool for the Analysis of Adrenal Disorders? 1990 ·Hormone Research ·B. Aupetit-Faisant	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact